Asymmetry in the Implantation of Self-Expanding Valves in TAVR: Evolution at 5 Years

Severe aortic stenosis is frequently associated with significant and irregular calcification, which tends to be more present in the non-coronary sinus. Incomplete valve expansion, observable through fluoroscopy after implantation, can lead to alterations in the hemodynamic profile and favor structural deterioration of the percutaneous aortic valve.

Currently, both the true impact of incomplete expansion and the degree of expansion required to result in hemodynamic alterations or future adverse events remain unclear.

In this context, researchers conducted an analysis on 1216 patients who underwent transcatheter aortic valve replacement (TAVR) with SAPIEN or SAPIEN 3 balloon-expandable valves. The asymmetry index was assessed using the following formula (%): (greater height/lesser height) – 1 × 100. The result was considered high when it exceeded 5.5%.

A high asymmetry index (HAI) was observed in 206 patients (17.2%). Average patient age was 81 years, and 34% of subjects were women, with an STS mortality risk score of 4.3%. Most patients were functional class III-IV.

Seven percent of cases involved bicuspid valves, with an aortic valve area of 0.78 cm² and an ejection fraction of 55%. The average annular diameter was 25 mm. Patients with a HAI had higher gradients (65 mmHg vs. 60 mmHg for peak gradient and 43 mmHg vs. 39 mmHg for mean gradient, respectively).

Read also: Aortic Stenosis with High Gradients and Area >1: Just Follow Up?

A mean gradient ≥20 mmHg was more frequent in patients with HAI (18.7% [n = 39] vs. 1.2% [n = 12]; odds ratio [OR]: 19.34; 95% confidence interval [CI]: 9.32-40.16; P <0.001), and so was the presence of moderate to higher paravalvular leak (5.7% [n = 12] vs. 0.3% [n = 3]; OR: 19.70; 95% CI: 5.35-72.58; P <0.001).

In the receiver operating characteristics (ROC) curve analysis, asymmetry proved to be an excellent predictor of hemodynamic performance alterations in balloon-expandable valves (0.88; 95% CI: 0.84-0.92; P <0.001), with a cut-off point >5%, which had a 77-% sensitivity and an 86-% specificity.

Structural deterioration was similar between groups (3.9% vs. 3.6%; OR: 1.21; 95% CI: 0.51-2.86; P = 0.670). At 30 days, there were no differences in all-cause mortality or cardiovascular mortality (1.4% vs. 1.7% and 1% vs. 1.3%, respectively). There were also no differences in the incidence of mortality and stroke at one year.

Read also: SCAAR Registry: Coronary Angioplasty in Venous Grafts.

At 5 years of follow-up, there were no differences in all-cause mortality or cardiac mortality (21.1% vs. 26.2% and 13.9% vs. 17.6%, for HAI and for those without asymmetry, respectively).

Conclusion

The asymmetric expansion of balloon-expandable valves was associated with hemodynamic alterations in their functioning but did not impact long-term clinical outcomes.

Original Title: Asymmetrical Expansion of Balloon-Expandable Transcatheter Aortic Valve Prostheses Implications for Valve Hemodynamic and Clinical Outcomes.

Reference: Annette Maznyczka, et al. JACC Cardiovasc Interv. 2024;17:2011–2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

OPTION Trial: Left Atrial Appendage Closure

Atrial fibrillation ablation is a valid strategy. However, reoccurrence is frequent in these cases, often with asymptomatic presentation. Anticoagulation with warfarin has proven effective in...

TRI-SPA Study: Tricuspid Edge-to-Edge Treatment

Tricuspid regurgitation (TR) is a condition associated with high morbidity and mortality. Currently, surgery is the recommended treatment; however, it carries a high complication...

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...